可溶性半乳糖凝集素3結合蛋白(LGALS3BP)單克隆抗體
Monoclonal Antibody to Lectin Galactoside Binding, Soluble 3 Binding Protein (LGALS3BP)
MAC-2-BP; LGALS3-BP; Galectin-3-Binding Protein; L3 Antigen; Mac-2-Binding Protein; Tumor-associated antigen 90K; Serum Protein 90K; Basement membrane autoantigen p105
- 編號MAB766Hu22
- 物種Homo sapiens (Human，人) 相同的名稱，不同的物種。
- 來源單抗制備
- 宿主小鼠
- 效價(克隆號)D5
- Ig亞型 IgG2b Kappa
- 純化方式蛋白A + 蛋白G親和純化
- 標記物無標記物
- 免疫原 RPB766Hu01-可溶性半乳糖凝集素3結合蛋白(LGALS3BP)重組蛋白
- 緩沖液成份磷酸鹽緩沖液（pH7.4,含有0.02% NaN3和50%甘油）
- 性狀液體
- 濃度1mg/mL
- 且適物種Rattus norvegicus (Rat，大鼠)
- 應用WB; IHC; ICC; IP.
如果抗體需用于流式細胞術，請參見流式抗體。 - 下載 英文說明書 中文說明書
- 規(guī)格 20μl100μl 200μl 1ml 10ml
- 價格 ¥ 634 ¥ 1478 ¥ 2112 ¥ 5280 ¥ 21120
- 欲了解實際交易價格和更多情況，請與當?shù)亟?jīng)銷商聯(lián)系!
-
產(chǎn)品包裝(模擬)
-
產(chǎn)品包裝(模擬)
-
DAB staining on IHC-P; Samples: Human Stomach Tissue; Primary Ab: 20μg/ml Mouse Anti-Human LGALS3BP Antibody Second Ab: 2μg/mL?HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody (Catalog: SAA544Mu19)
-
DAB staining on IHC-P;
Samples: Human Prostate Tissue;
Primary Ab: 20μg/ml Mouse Anti-Human LGALS3BP Antibody
Second Ab: 2μg/mL?HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody
(Catalog: SAA544Mu19)
-
Western Blot; Sample: Rat Cerebrum lysate; Primary Ab: 3μg/ml Mouse Anti-Human LGALS3BP Antibody Second Ab: 0.2μg/mL?HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody (Catalog: SAA544Mu19)
-
Western Blot; Sample: Rat Small intestine lysate;
Primary Ab: 3μg/ml Mouse Anti-Human LGALS3BP Antibody
Second Ab: 0.2μg/mL?HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody
(Catalog: SAA544Mu19) -
Western Blot; Sample: Human 293T cell lysate;
Primary Ab: 3μg/ml Mouse Anti-Human LGALS3BP Antibody
Second Ab: 0.2μg/mL?HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody
(Catalog: SAA544Mu19) -
Western Blot; Sample: Human HepG2 cell lysate;
Primary Ab: 3μg/ml Mouse Anti-Human LGALS3BP Antibody
Second Ab: 0.2μg/mL?HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody
(Catalog: SAA544Mu19)
-
通過ISO 9001、ISO 13485質(zhì)量體系認證
特異性
該抗體是針對LGALS3BP的小鼠單克隆抗體。在免疫組織化學染色和免疫印跡實驗中能識別LGALS3BP。
用法
Western blotting: 0.01-3μg/mL;
Immunohistochemistry: 5-20μg/mL;
Immunocytochemistry: 5-20μg/mL;
Optimal working dilutions must be determined by end user.
儲存
經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當?shù)臈l件下存儲，損失率低于5%。
贈品
增值服務
相關產(chǎn)品
| 編號 | 適用物種：Homo sapiens (Human，人) | 應用(僅供研究使用，不用于臨床診斷！) |
| RPB766Hu01 | 可溶性半乳糖凝集素3結合蛋白(LGALS3BP)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAB766Hu01 | 可溶性半乳糖凝集素3結合蛋白(LGALS3BP)多克隆抗體 | WB; IHC; ICC; IP. |
| MAB766Hu22 | 可溶性半乳糖凝集素3結合蛋白(LGALS3BP)單克隆抗體 | WB; IHC; ICC; IP. |
| MAB766Hu21 | 可溶性半乳糖凝集素3結合蛋白(LGALS3BP)單克隆抗體 | WB,IHC |
| FAB766Hu02 | 抗可溶性半乳糖凝集素3結合蛋白(LGALS3BP)單克隆抗體 | Flow cytometry. |
| FAB766Hu04 | 抗可溶性半乳糖凝集素3結合蛋白(LGALS3BP)單克隆抗體 | Flow cytometry. |
| FAB766Hu06 | 抗可溶性半乳糖凝集素3結合蛋白(LGALS3BP)單克隆抗體 | Flow cytometry. |
| FAB766Hu08 | 抗可溶性半乳糖凝集素3結合蛋白(LGALS3BP)單克隆抗體 | Flow cytometry. |
| LAB766Hu72 | 可溶性半乳糖凝集素3結合蛋白(LGALS3BP)單克隆抗體(生物素標記) | WB; IHC; ICC. |
| SEB766Hu | 可溶性半乳糖凝集素3結合蛋白(LGALS3BP)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMB766Hu | 可溶性半乳糖凝集素3結合蛋白(LGALS3BP)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
| PSB766Hu01 | 可溶性半乳糖凝集素3結合蛋白(LGALS3BP)抗體對 | ELISA; CLIA; ELISPOT; Luminex; Immunochromatography and other Immunoassays. |
| KSB766Hu01 | 可溶性半乳糖凝集素3結合蛋白(LGALS3BP)檢測試劑盒DIY材料(酶聯(lián)免疫吸附試驗法) | Main materials for "Do It (ELISA Kit) Yourself". |
參考文獻
| 雜志 | 參考文獻 |
| Andrology | Comparative proteomic analysis coupled with conventional protein assay as a strategy to identify predictors of successful testicular sperm extraction in patients with non-obstructive azoospermia [PubMed: 23427166] |
| Liver International | Identification of candidate biomarkers for hepatocellular carcinoma in plasma of HCV-infected cirrhotic patients by 4-D DIGE [Pubmed: 23944848] |
| Acta?Anaesthesiologica Scandinavica | Early prognostic factors in septic shock cancer patients: a prospective study with a proteomic approach [Pubmed:29315472] |
留言咨詢
